Skip to main content
. 2019 Apr 27;36(8):1768–1782. doi: 10.1093/molbev/msz104

Fig. 8.

Fig. 8.

Survival curves of C57BL/6J mice systemically infected with wild-type or HU-evolved Candida albicans strains harboring either ChrRx3 or Chr2x3, with or without CSP treatment. CSP was administered intraperitoneally at a dose of 0.063 mg/kg body weight daily for 7 days, beginning 1 day after infection. Control mice were administered 100 μl of phosphate buffered saline intraperitoneally. Survival curves were compared using the log-rank test.